Kinetics of the Solution-Mediated Polymorphic Transformation of Organic Compounds

被引：7
作者：
Wantha, Lek [1 ]
机构：
[1] Burapha Univ, Fac Engn, Dept Chem Engn, 169 Long Hard Bangsaen Rd, Chon Buri 20131, Thailand
来源：
CURRENT PHARMACEUTICAL DESIGN | 2018年 / 24卷 / 21期
关键词：
Polymorphism; organic compound; crystallization from solution; kinetics; solution-mediated polymorphic transformation; process modelling; L-GLUTAMIC ACID; ACTIVE PHARMACEUTICAL INGREDIENTS; POPULATION BALANCE MODEL; DRUG-DELIVERY SYSTEM; FORM III PIRACETAM; SOLID-STATE; NUCLEATION KINETICS; CRYSTALLIZATION BEHAVIOR; DISSOLUTION KINETICS; PHASE-TRANSFORMATION;
D O I：
10.2174/1381612824666180601093228
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Polymorphism is a behavior of a substance to crystallize into more than one district crystal structures. Preferential formation of a polymorph depends strongly on the kinetics of the relevant mechanisms. Solution-mediated polymorphic transformation is an important mechanism in crystallization of organic compounds from solution. Knowing its kinetics allows us to understand the process and control the polymorphic formation. In this review, concepts, kinetics, and process modeling of crystallization and solution-mediated polymorphic transformation are examined and summarized.
引用
收藏
页码：2383 / 2393
页数：11
相关论文
共 50 条
[1]   Solution-Mediated Polymorphic Transformation of FV Sulphathiazole [J].
Munroe, Aine ;
Croker, Denise M. ;
Rasmuson, Ake C. ;
Hodnett, Benjamin K. .
CRYSTAL GROWTH & DESIGN, 2014, 14 (07) :3466-3471
[2]   Solid-State and Solution-Mediated Polymorphic Transformation of Rifampicin [J].
Jing, Dingding ;
Gu, Yuan ;
Xia, Huiming .
CHEMICAL ENGINEERING & TECHNOLOGY, 2018, 41 (06) :1236-1243
[3]   Examining Solution and Solid State Composition for the Solution-Mediated Polymorphic Transformation of Carbamazepine and Piracetam [J].
O'Mahony, Marcus A. ;
Maher, Anthony ;
Croker, Denise M. ;
Rasmuson, Ake C. ;
Hodnett, Benjamin K. .
CRYSTAL GROWTH & DESIGN, 2012, 12 (04) :1925-1932
[4]   Solution-mediated polymorphic transformation of CL-20: An approach to prepare purified form ε particles [J].
Pan, Bochen ;
Wei, Hongyuan ;
Jiang, Jun ;
Zong, Shanghong ;
Lv, Penghao ;
Dang, Leping .
JOURNAL OF MOLECULAR LIQUIDS, 2018, 265 :216-225
[5]   Influence of Solvents on Solution-Mediated Polymorphic Transformation of the Polymorphs of L-Histidine [J].
Wantha, Lek ;
Punmalee, Neeranuch ;
Flood, Adrian E. .
CHEMICAL ENGINEERING & TECHNOLOGY, 2019, 42 (07) :1505-1511
[6]   Kinetics of the Solution-Mediated Polymorphic Transformation of the Novel L-Carnitine Orotate Polymorph, Form-II [J].
An, Ji-Hun ;
Youn, Wonno ;
Kiyonga, Alice Nguvoko ;
Lim, Changjin ;
Park, Minho ;
Suh, Young-Ger ;
Ryu, Hyung Chul ;
Kim, Jae Sun ;
Park, Chun-Woong ;
Jung, Kiwon .
PHARMACEUTICS, 2018, 10 (04)
[7]   Mechanism and Regulation Strategy of Solution-Mediated Polymorphic Transformation: A Case of 5-Nitrofurazone [J].
Li, Xin ;
Wang, Na ;
Wang, Chang ;
Ma, Yingjie ;
Huang, Xin ;
Wang, Ting ;
Hao, Hongxun .
INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH, 2021, 60 (05) :2337-2347
[8]   Response surface analysis of solution-mediated polymorphic transformation of buspirone hydrochloride [J].
Sheikhzadeh, A. ;
Murad, S. ;
Rohani, S. .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2007, 45 (02) :227-236
[9]   Influence Factor Investigation on the Solution-Mediated Polymorphic Transformation of Baricitinib Phosphate [J].
Hong, Minghuang ;
Guo, Sai ;
Wang, Kai ;
Ma, Lei ;
Ren, Guobin .
ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE, 2018, 644 (15) :849-855
[10]   Solution-Mediated Polymorphic Transformation: From Amorphous to Crystals of Disodium Guanosine 5′-Monophosphate in Ethanol [J].
Zou, Fengxia ;
Chen, Qiao ;
Yang, PengPeng ;
Zhou, Jingwei ;
Wu, Jinglan ;
Zhuang, Wei ;
Ying, Hanjie .
INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH, 2017, 56 (29) :8274-8282
12345